Source link : https://newshealth.biz/health-news/a-look-at-the-phase-ii-saga-data-for-gildeuretinol-in-geographic-atrophy/
(MedPage Today) — An oral investigational agent, gildeuretinol (ALK-001), demonstrated a significant reduction in geographic atrophy (GA) lesion growth and improvements in low luminance visual function in the phase II SAGA trial, according to… Source link : https://www.medpagetoday.com/meetingcoverage/arvovideopearls/115716 Author : Publish date : 2025-05-22 15:58:00 Copyright for syndicated content belongs to the linked Source.
The post A Look at the Phase II SAGA Data for Gildeuretinol in Geographic Atrophy first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-22 15:58:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8